coronavirus
cov
envelop
singl
posit
strand
rna
virus
belong
subfamili
coronavirina
cov
genom
rang
kilobas
length
probabl
largest
viral
rna
known
previous
six
cov
known
caus
human
diseas
divid
low
pathogen
highli
pathogen
cov
low
pathogen
cov
includ
account
upper
respiratori
tract
infect
typic
caus
mild
respiratori
diseas
contrast
highli
pathogen
cov
includ
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
cov
predominantli
infect
lower
airway
caus
fatal
pneumonia
sarscov
emerg
new
human
infect
south
china
novemb
end
juli
infect
peopl
caus
death
overal
mortal
rate
merscov
anoth
highli
pathogen
cov
first
emerg
saudi
arabiawa
caus
total
laboratoryconfirm
case
death
countri
mortal
rate
sinc
septemb
http
wwwwhointemerg
merscoven
two
highli
pathogen
pose
substanti
threat
public
health
late
decemb
novel
cov
identifi
pathogen
caus
outbreak
sarslik
ill
chines
citi
wuhan
offici
name
world
health
organ
subsequ
full
genom
sequenc
shanghai
public
health
clinic
center
argu
bat
origin
begin
cluster
case
novel
cov
infect
report
epidemiolog
link
huanan
seafood
wholesal
market
subsequ
evid
humantohuman
transmiss
confirm
infect
healthcar
practition
close
contact
infect
patient
wuhan
hospit
februari
infect
total
case
world
despit
sever
decad
research
lack
specif
vaccin
treatment
human
cov
review
summar
advanc
natur
clinic
characterist
therapeut
may
critic
respons
outbreak
belong
lineag
b
subgenu
sarbecoviru
possess
singlestrand
positivesens
rna
surround
envelop
fig
recent
phylogenet
analysi
reveal
close
relat
batcov
yunnan
china
sequenc
ident
correl
two
batderiv
sarslik
coronavirus
approxim
ident
came
zhoushan
china
howev
discord
sarscov
approxim
ident
merscov
approxim
ident
genom
consist
six
major
function
open
read
frame
orf
includ
e
n
sever
accessori
gene
replicas
polyprotein
would
proteolyt
cleav
nonstructur
protein
nsp
involv
transcript
replic
viru
addit
encod
complet
novel
short
protein
without
exact
function
new
like
encod
secret
protein
form
alphahelix
follow
betasheet
contain
six
strand
known
function
domain
motif
similarli
gene
less
sequenc
ident
two
cov
bat
sarslik
cov
human
sarscov
similarli
spike
glycoprotein
encod
gene
longer
sarscov
spike
protein
compos
domain
crucial
determin
host
tropism
transmiss
capac
mediat
receptor
bind
membran
fusion
among
subunit
highli
conserv
ident
sarscov
receptorbind
domain
commonli
locat
ctermin
domain
directli
contact
human
receptor
although
domain
approxim
ident
sarscov
homolog
model
reveal
similar
receptorbind
domain
structur
sarscov
notabl
zhou
et
al
found
like
sarscov
may
also
use
entri
receptor
cell
major
type
ii
alveolar
cell
human
lung
therefor
investig
need
determin
whether
target
drug
would
effect
treatment
sinc
genom
sequenc
obtain
differ
patient
extrem
similar
exhibit
sequenc
ident
could
reason
consid
origin
one
sourc
rather
mosaic
could
detect
rel
rapidli
howev
mutat
need
constantli
monitor
viru
transmit
increas
number
individu
basi
initi
investig
share
histori
exposur
wuhan
seafood
wholesal
market
highli
suggest
wild
anim
sold
market
bamboo
rat
raccoon
snake
would
origin
sourc
novel
viru
soon
afterward
traceabl
analysi
support
would
rhinolophu
phylogenet
analysi
result
relat
batcov
bat
howev
intermedi
host
like
exist
bat
human
similar
mask
palm
civet
dromedari
camel
merscov
newest
research
suspect
pangolin
potenti
intermedi
host
novel
coronaviru
may
epidemiolog
highli
infecti
h
surviv
time
air
incub
period
infect
gener
day
age
group
suscept
viru
elderli
patient
comorbid
like
experi
sever
ill
importantli
peopl
primari
asymptomat
incub
period
main
sourc
infect
critic
signific
epidem
prevent
control
respiratori
droplet
major
rout
transmiss
besid
fecalor
rout
transmiss
consid
unconfirm
nucleic
acid
could
detect
stool
sampl
pneumonia
patient
abdomin
symptom
vertic
transmiss
mother
infant
anoth
possibl
rout
base
find
hold
newborn
confirm
wuhan
children
hospit
research
also
warn
transmiss
ocular
surfac
must
ignor
consid
human
conjunctiv
epithelium
contamin
easili
infecti
droplet
bodi
fluid
knowledg
basic
reproduct
rate
rate
reflect
speed
diseas
transmiss
differ
time
period
estim
research
also
substanti
affect
report
rate
latest
estim
wu
et
al
roughli
ident
rate
publish
chines
center
diseas
control
indic
number
infect
patient
increas
long
greater
result
declar
outbreak
pneumonia
public
health
emerg
intern
concern
januari
adopt
control
measur
reduc
rate
global
present
clinic
data
obtain
provinc
china
reveal
share
mani
clinic
featur
sarscov
median
age
patient
year
old
predomin
male
patient
mean
incub
time
day
rang
day
common
symptom
fever
fatigu
dri
cough
myalgia
accompani
rhinobyon
rhinorrhoea
pharyngalgia
diarrhea
patient
tabl
notabl
fever
may
necessarili
first
manifest
occur
patient
initi
present
part
patient
character
dyspnea
hypoxemia
rapidli
progress
acut
respiratori
distress
syndrom
ard
septic
shock
metabol
acidosi
coagul
dysfunct
even
multipl
organ
dysfunct
syndrom
mod
one
week
laboratori
test
could
provid
hint
earli
form
diseas
lymphopenia
thrombocytopenia
leukopenia
patient
demonstr
elev
level
creactiv
protein
crp
addit
sever
case
could
increas
level
alanin
aminotransferas
aspart
aminotransferas
creatin
kinas
creatin
suspect
patient
recommend
examin
chest
computer
tomographi
ct
confirm
patient
suffer
pneumonia
character
groundglass
opac
bilater
patchi
shadow
chest
ct
even
subsegment
consolid
sever
patient
date
patient
good
prognosi
howev
mortal
rate
higher
elder
patient
chronic
diseas
diabet
hypertens
angiocardiopathi
etc
intens
care
unit
icu
patient
reach
recent
report
diagnosi
base
epidemiolog
risk
clinic
featur
laboratori
test
patient
histori
travel
chines
citi
wuhan
close
contact
confirm
suspect
case
present
fever
respiratori
symptom
within
incub
period
suspect
addit
due
discoveri
asymptomat
covcarri
neg
viral
nucleic
acid
test
mani
time
comfirm
typic
pulmonari
imag
perform
ignor
even
use
preliminari
screen
method
posit
viral
nucleic
acid
realtim
rtpcr
detect
specimen
respiratori
tract
serum
confirm
infect
despit
sever
therapeut
option
experi
infect
patient
still
specif
therapi
one
kind
rna
viru
may
possess
similar
function
protein
process
viru
replic
assembl
human
immunodefici
viru
hiv
thu
hiv
proteas
inhibitor
may
also
effect
present
lopinavirritonavir
lpvr
combin
previous
confirm
effect
sarscov
merscov
recommend
treatment
latest
guidelin
besid
homolog
model
molecular
dock
anoth
antihiv
drug
nelfinavir
predict
activ
could
potenti
drug
remdesivir
rdv
novel
nucleotid
analogu
prodrug
develop
prove
potenti
effect
pancov
antivir
wang
et
al
show
rdv
could
inhibit
infect
vitro
success
use
rdv
first
case
unit
state
post
bright
perspect
promisingli
random
doubleblind
parallelcontrol
phase
clinic
trial
safeti
efficaci
rdv
ongo
wuhan
meanwhil
wang
colleagu
also
provid
evid
potenti
chloroquin
also
effect
control
infect
arbidol
broadspectrum
antivir
activ
respiratori
virus
recent
news
report
arbidol
inhibit
vitro
phase
clinic
trial
arbidol
new
coronaviru
pneumonia
regist
monoclon
antibodi
mab
sever
research
show
combin
rdv
mab
would
like
ideal
treatment
tian
et
al
report
first
time
sarscovspecif
human
mab
could
bind
potent
receptor
bind
domain
therefor
may
develop
prevent
treat
new
coronaviru
infect
addit
janu
kinas
inhibitor
baricitinib
disrupt
receptor
mediat
endocytosi
interrupt
passag
viru
cell
identifi
reduc
abil
viru
infect
lung
cell
potenti
treatment
addit
therapeut
discuss
chines
healthcar
practition
also
start
clinic
trail
stem
cell
infus
tradit
chines
medicin
sever
patient
expect
therapi
improv
clinic
outcom
patient
world
experienc
three
outbreak
highli
pathogen
cov
includ
emerg
sarscov
merscov
outbreak
clear
anoth
lineag
b
postul
bat
primari
host
despit
similar
genet
sequenc
sarscov
share
mani
featur
sarscov
epidemiolog
clinic
characterist
entri
receptor
jump
unpredict
spread
rapidli
pose
sever
threat
public
health
although
overal
mortal
rate
lower
sarscov
marscov
mortal
elder
patient
chronic
diseas
intens
care
unit
icu
patient
reach
recent
report
yet
specif
therapi
proven
efficaci
recommend
human
cov
infect
retrospect
analysi
show
death
cov
infect
patient
due
sever
pneumonia
previou
studi
indic
viral
evas
host
maladjust
immun
respons
believ
play
critic
role
acut
lung
injuri
ali
addit
covsinduc
direct
cytopath
effect
inde
chang
immun
index
detect
cov
infect
patient
lymphopenia
monocytosi
elev
cytokin
level
treatment
corticosteroid
may
reduc
risk
lung
inflamm
also
delay
cov
clearanc
addit
side
effect
thu
topic
corticosteroid
use
patient
cov
matter
debat
year
avail
clinic
data
tend
argu
net
benefit
deriv
corticosteroid
treatment
sarscov
merscov
recent
studi
largest
case
seri
wuhan
show
effect
outcom
observ
usag
vari
dose
methylprednisolon
outbreak
pose
seriou
challeng
china
current
effect
measur
still
earli
detect
quarantin
new
sourc
infect
earli
diagnosi
support
treatment
confirm
patient
consider
advanc
made
prevent
control
emerg
infecti
diseas
sinc
sarscov
epidem
year
ago
addit
base
success
therapi
sarscov
seri
effect
treatment
adopt
patient
therefor
confid
would
effect
curb
outbreak
epidem
peak
may
soon
reach
final
victori
far
away
author
declar
compet
interest
correspond
author
doctor
particip
fight
frontlin
author
grate
acknowledg
memori
doctor
wenliang
li
first
step
warn
public
outbreak
novel
viru
well
thousand
unsung
hero
fight
epidem
research
support
nation
natur
scienc
foundat
china
